天津科創醫藥中間體技術生產力促進有限公司

Tianjin Science and Technology Innovation Pharmaceutical Intermediates Technology Productivity Promotion Co., Ltd. is a technology-based enterprise integrating industrial production, scientific research and development, and self-operated import and export sales of pharmaceutical raw materials and intermediates. The company has strong advantages in scientific research and development, pilot-scale production, and large-scale industrial production. It boasts a team of synthetic process engineers, including doctors and masters with high expertise in organic chemistry, pharmaceutical chemistry, and other disciplines, and possesses unique advantages in the pilot production and optimization of complex bioactive molecules. The company is equipped with comprehensive scientific research and experimental facilities, including state-of-the-art analytical and testing instruments such as Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Gas Chromatography (GC), and High-Performance Liquid Chromatography (HPLC).

In addition, the company is committed to promoting industry-university-research collaboration, building a technological innovation platform for the step-by-step scale-up of synthetic processes in the biomedical field, improving the biomedical industry chain, accelerating the formation of industrial clusters, and helping small and medium-sized enterprises (SMEs) overcome key technological and process development challenges to facilitate their rapid growth into technology-based "little giant" enterprises. By addressing the initial development bottlenecks of SMEs and providing diversified services, the company serves as an information bridge between enterprises and the government, between enterprises and technology, between enterprises and the market, and among enterprises themselves. This enhances the technological innovation capabilities and market competitiveness of enterprises, enabling them to more accurately grasp the pulse of contemporary technology and embark on a path of independent innovation and rapid development.